BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 37582796)

  • 1. Nationwide spatiotemporal drug resistance genetic profiling from over three decades in Indian Plasmodium falciparum and Plasmodium vivax isolates.
    Kojom Foko LP; Narang G; Jakhan J; Tamang S; Moun A; Singh V
    Malar J; 2023 Aug; 22(1):236. PubMed ID: 37582796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of drug resistance genes in Indian Plasmodium falciparum and Plasmodium vivax field isolates.
    Narang G; Jakhan J; Tamang S; Yadav K; Singh V
    Acta Trop; 2024 Jul; 255():107218. PubMed ID: 38636585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of molecular markers of anti-malarial drug resistance in Plasmodium vivax and Plasmodium falciparum in two districts of Nepal.
    Ranjitkar S; Schousboe ML; Thomsen TT; Adhikari M; Kapel CM; Bygbjerg IC; Alifrangis M
    Malar J; 2011 Apr; 10():75. PubMed ID: 21457533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of high levels of mutations involved in anti-malarial drug resistance in Plasmodium falciparum and Plasmodium vivax at a rural hospital in southern Ethiopia.
    Mula P; Fernández-Martínez A; de Lucio A; Ramos JM; Reyes F; González V; Benito A; Berzosa P
    Malar J; 2011 Aug; 10():214. PubMed ID: 21810256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal trends in molecular markers of drug resistance in Plasmodium falciparum in human blood and profiles of corresponding resistant markers in mosquito oocysts in Asembo, western Kenya.
    Zhou Z; Gimnig JE; Sergent SB; Liu Y; Abong'o B; Otieno K; Chebore W; Shah MP; Williamson J; Ter Kuile FO; Hamel MJ; Kariuki S; Desai M; Samuels AM; Walker ED; Shi YP
    Malar J; 2022 Sep; 21(1):265. PubMed ID: 36100912
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Longitudinal ex vivo and molecular trends of chloroquine and piperaquine activity against Plasmodium falciparum and P. vivax before and after introduction of artemisinin-based combination therapy in Papua, Indonesia.
    Marfurt J; Wirjanata G; Prayoga P; Chalfein F; Leonardo L; Sebayang BF; Apriyanti D; Sihombing MAEM; Trianty L; Suwanarusk R; Brockman A; Piera KA; Luo I; Rumaseb A; MacHunter B; Auburn S; Anstey NM; Kenangalem E; Noviyanti R; Russell B; Poespoprodjo JR; Price RN
    Int J Parasitol Drugs Drug Resist; 2021 Dec; 17():46-56. PubMed ID: 34193398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of molecular markers of antimalarial drug resistance in Plasmodium falciparum and Plasmodium vivax in Federally Administered Tribal Area (FATA), Pakistan.
    Nadeem MF; Khattak AA; Zeeshan N; Zahid H; Awan UA; Yaqoob A; Ashraf NM; Gul S; Alam S; Ahmed W
    Rev Inst Med Trop Sao Paulo; 2021; 63():e59. PubMed ID: 34407160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular surveillance of anti-malarial drug resistance genes in Plasmodium falciparum isolates in Odisha, India.
    Rana R; Khan N; Sandeepta S; Pati S; Das A; Bal M; Ranjit M
    Malar J; 2022 Dec; 21(1):394. PubMed ID: 36566182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Markers of anti-malarial drug resistance in Plasmodium falciparum isolates from Swaziland: identification of pfmdr1-86F in natural parasite isolates.
    Dlamini SV; Beshir K; Sutherland CJ
    Malar J; 2010 Mar; 9():68. PubMed ID: 20199676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug resistance of Plasmodium falciparum and Plasmodium vivax isolates in Indonesia.
    Rahmasari FV; Asih PBS; Dewayanti FK; Rotejanaprasert C; Charunwatthana P; Imwong M; Syafruddin D
    Malar J; 2022 Nov; 21(1):354. PubMed ID: 36443817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Significant geographical differences in prevalence of mutations associated with Plasmodium falciparum and Plasmodium vivax drug resistance in two regions from Papua New Guinea.
    Barnadas C; Timinao L; Javati S; Iga J; Malau E; Koepfli C; Robinson LJ; Senn N; Kiniboro B; Rare L; Reeder JC; Siba PM; Zimmerman PA; Karunajeewa H; Davis TM; Mueller I
    Malar J; 2015 Oct; 14():399. PubMed ID: 26452541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of Plasmodium falciparum drug resistance associated molecular markers in Mandla, Madhya Pradesh, India.
    Singh A; Singh MP; Ali NA; Poriya R; Rajvanshi H; Nisar S; Bhandari S; Sahu RS; Jayswar H; Mishra AK; Das A; Kaur H; Anvikar AR; Escalante AA; Lal AA; Bharti PK
    Malar J; 2023 Dec; 22(1):375. PubMed ID: 38072967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan.
    Khattak AA; Venkatesan M; Jacob CG; Artimovich EM; Nadeem MF; Nighat F; Hombhanje F; Mita T; Malik SA; Plowe CV
    Malar J; 2013 Aug; 12():300. PubMed ID: 23988011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased prevalence of pfdhfr and pfdhps mutations associated with sulfadoxine-pyrimethamine resistance in Plasmodium falciparum isolates from Jazan Region, Southwestern Saudi Arabia: important implications for malaria treatment policy.
    Madkhali AM; Al-Mekhlafi HM; Atroosh WM; Ghzwani AH; Zain KA; Abdulhaq AA; Ghailan KY; Anwar AA; Eisa ZM
    Malar J; 2020 Dec; 19(1):446. PubMed ID: 33267841
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Malaria in Venezuela: changes in the complexity of infection reflects the increment in transmission intensity.
    Pacheco MA; Forero-Peña DA; Schneider KA; Chavero M; Gamardo A; Figuera L; Kadakia ER; Grillet ME; Oliveira-Ferreira J; Escalante AA
    Malar J; 2020 May; 19(1):176. PubMed ID: 32380999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant pfcrt "SVMNT" haplotype and wild type pfmdr1 "N86" are endemic in Plasmodium vivax dominated areas of India under high chloroquine exposure.
    Mallick PK; Joshi H; Valecha N; Sharma SK; Eapen A; Bhatt RM; Srivastava HC; Sutton PL; Dash AP; Bhasin VK
    Malar J; 2012 Jan; 11():16. PubMed ID: 22236376
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surveillance of drug resistance molecular markers in Plasmodium vivax before and after introduction of dihydroartemisinin and piperaquine in Thailand: 2009-2019.
    Suphakhonchuwong N; Rungsihirunrat K; Kuesap J
    Parasitol Res; 2023 Dec; 122(12):2871-2883. PubMed ID: 37725258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of molecular markers of drug resistance in Plasmodium vivax from the border regions of Thailand in 2008 and 2014.
    Tantiamornkul K; Pumpaibool T; Piriyapongsa J; Culleton R; Lek-Uthai U
    Int J Parasitol Drugs Drug Resist; 2018 Aug; 8(2):229-237. PubMed ID: 29677637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug resistance genes: pvcrt-o and pvmdr-1 polymorphism in patients from malaria endemic South Western Coastal Region of India.
    Joy S; Mukhi B; Ghosh SK; Achur RN; Gowda DC; Surolia N
    Malar J; 2018 Jan; 17(1):40. PubMed ID: 29351800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of drug resistance associated genetic diversity in Mauritanian isolates of Plasmodium vivax reveals limited polymorphism.
    Mint Deida J; Ould Khalef Y; Mint Semane E; Ould Ahmedou Salem MS; Bogreau H; Basco L; Ould Mohamed Salem Boukhary A; Tahar R
    Malar J; 2018 Nov; 17(1):416. PubMed ID: 30409138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.